Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Induced Pluripotent Stem Cells | 1 | 2023 | 243 | 0.680 |
Why?
|
| Transcription Factors | 1 | 2023 | 2440 | 0.410 |
Why?
|
| Gene Regulatory Networks | 2 | 2026 | 380 | 0.370 |
Why?
|
| Atrial Fibrillation | 2 | 2026 | 734 | 0.250 |
Why?
|
| T-Box Domain Proteins | 1 | 2026 | 120 | 0.220 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2023 | 20 | 0.210 |
Why?
|
| Adult Stem Cells | 1 | 2022 | 51 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2026 | 564 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2022 | 130 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2021 | 38 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2026 | 815 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2023 | 569 | 0.160 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 215 | 0.160 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 134 | 0.160 |
Why?
|
| Dopamine | 1 | 2021 | 250 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2023 | 988 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 665 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 1320 | 0.140 |
Why?
|
| Monocytes | 1 | 2020 | 335 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 361 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 2340 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 675 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 57 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 140 | 0.120 |
Why?
|
| Mice | 5 | 2026 | 18222 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2026 | 2343 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 288 | 0.110 |
Why?
|
| Aging | 1 | 2021 | 1252 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 998 | 0.100 |
Why?
|
| Heart Failure | 1 | 2026 | 2316 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1390 | 0.090 |
Why?
|
| Animals | 6 | 2026 | 33897 | 0.090 |
Why?
|
| Mitochondria | 1 | 2017 | 761 | 0.090 |
Why?
|
| Neoplasms | 1 | 2026 | 2951 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2017 | 719 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2647 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2026 | 110 | 0.060 |
Why?
|
| Humans | 8 | 2026 | 130573 | 0.060 |
Why?
|
| SOX9 Transcription Factor | 1 | 2026 | 89 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2026 | 146 | 0.060 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 136 | 0.060 |
Why?
|
| Heart Atria | 1 | 2026 | 335 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 4663 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2022 | 78 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2022 | 72 | 0.050 |
Why?
|
| Cell Division | 1 | 2022 | 713 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 4700 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2022 | 220 | 0.040 |
Why?
|
| Antigens, Ly | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2022 | 595 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 434 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 341 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2026 | 3834 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 3 | 0.030 |
Why?
|
| Norway | 1 | 2017 | 29 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2017 | 35 | 0.030 |
Why?
|
| Albuterol | 1 | 2017 | 53 | 0.030 |
Why?
|
| Propranolol | 1 | 2017 | 111 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 182 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 488 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 213 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 160 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 274 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 734 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1154 | 0.030 |
Why?
|
| Aged | 2 | 2026 | 20926 | 0.030 |
Why?
|
| Male | 3 | 2026 | 64560 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1213 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 543 | 0.030 |
Why?
|
| Middle Aged | 2 | 2026 | 28450 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2468 | 0.020 |
Why?
|
| Adult | 2 | 2026 | 31204 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1382 | 0.020 |
Why?
|
| Female | 3 | 2026 | 70513 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6774 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3702 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9991 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 14987 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 20774 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17655 | 0.010 |
Why?
|
| Child | 1 | 2021 | 26148 | 0.010 |
Why?
|